1. Home
  2. PLBC vs RGNX Comparison

PLBC vs RGNX Comparison

Compare PLBC & RGNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Plumas Bancorp

PLBC

Plumas Bancorp

N/A

Current Price

$62.85

Market Cap

426.2M

Sector

Finance

ML Signal

N/A

Logo REGENXBIO Inc.

RGNX

REGENXBIO Inc.

N/A

Current Price

$7.65

Market Cap

487.2M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
PLBC
RGNX
Founded
1980
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Finance Companies
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
426.2M
487.2M
IPO Year
2002
2015

Fundamental Metrics

Financial Performance
Metric
PLBC
RGNX
Price
$62.85
$7.65
Analyst Decision
Buy
Strong Buy
Analyst Count
3
11
Target Price
★ $70.00
$21.40
AVG Volume (30 Days)
40.3K
★ 1.2M
Earning Date
10-21-2026
11-05-2026
Dividend Yield
★ 2.10%
N/A
EPS Growth
N/A
★ 18.08
EPS
★ 4.40
N/A
Revenue
N/A
★ $10,393,000.00
Revenue This Year
$17.30
N/A
Revenue Next Year
$2.72
$59.15
P/E Ratio
$14.31
★ N/A
Revenue Growth
N/A
★ 126.48
52 Week Low
$41.30
$5.46
52 Week High
$65.10
$16.19

Technical Indicators

Market Signals
Indicator
PLBC
RGNX
Relative Strength Index (RSI) 48.15 50.75
Support Level $62.15 $6.79
Resistance Level $63.60 $8.31
Average True Range (ATR) 1.12 0.60
MACD -0.12 0.12
Stochastic Oscillator 13.39 50.65

Price Performance

Historical Comparison
PLBC
RGNX

About PLBC Plumas Bancorp

Plumas Bancorp provides banking products and services in Northeastern California and Northwestern Nevada, offering a range of deposit products for commercial and retail customers, including checking, savings, money market accounts, time deposits, retirement accounts, and sweep accounts for businesses and public entities, along with digital banking services such as mobile and internet banking, remote deposit, and electronic funds transfers, as well as other customary banking services. Its loan portfolio comprises commercial real estate, commercial and industrial, consumer, agricultural, residential real estate, and construction and land development loans, and the company generates its revenue from loans and investment securities, with additional income from service fees.

About RGNX REGENXBIO Inc.

Regenxbio Inc is a clinical-stage biotechnology company focused on the development of gene therapy treatments. Its product candidates are designed to deliver genes to cells to address genetic defects or enable the production of therapeutic proteins. The company is developing a pipeline of investigational gene therapy treatments using its NAV Technology Platform based on adeno-associated virus (AAV) vectors. Its internal research and development programs are focused on therapies for retinal, neuromuscular, and neurodegenerative diseases.

Share on Social Networks: